Search Results - "Messner, H."

The risk of polyomavirus BK-associated hemorrhagic cystitis after allogeneic hematopoietic SCT is associated with myeloablative conditioning, CMV viremia and severe acute GVHD by Uhm, J, Hamad, N, Michelis, F V, Shanavas, M, Kuruvilla, J, Gupta, V, Lipton, J H, Messner, H A, Seftel, M, Kim, D D

“…Hemorrhagic cystitis (HC) is a common complication after allogeneic hematopoietic SCT (allo-HSCT). Several risk factors have been suggested including…”
Get full text

Clinically stable very low birthweight infants are at risk for recurrent tissue glucose fluctuations even after fully established enteral nutrition by Mola-Schenzle, E, Staffler, A, Klemme, M, Pellegrini, F, Molinaro, G, Parhofer, K G, Messner, H, Schulze, A, Flemmer, A W

“…In previous cases, we have observed occasional hypoglycaemic episodes in preterm infants after initial intensive care. In this prospective study, we determined…”
Get more information

Allogeneic hematopoietic cell transplantation for myelofibrosis using fludarabine-, intravenous busulfan- and low-dose TBI-based conditioning by Shanavas, M, Messner, H A, Atenafu, E G, Kim, D H, Kuruvilla, J, Lipton, J H, Uhm, J, Seftel, M, Alam, N, Gupta, V

“…Graft failure is one of the major barriers to the success of allogeneic hematopoietic cell transplantation (HCT) in myelofibrosis (MF). We report our…”
Get full text

Large granular lymphocytosis and its impact on long-term clinical outcomes following allo-SCT by (Dong Hwan) Kim, D, Al-Dawsari, G, Chang, H, Panzarella, T, Gupta, V, Kuruvilla, J, Lipton, J H, Messner, H A

“…A total of 418 patients receiving hematopoietic SCT and surviving beyond day 100 were examined for the occurrence of large granular lymphocytes (LGLs). LGL…”
Get full text

Duration of first remission, hematopoietic cell transplantation-specific comorbidity index and patient age predict survival of patients with AML transplanted in second CR by Michelis, F V, Atenafu, E G, Gupta, V, Kim, D D, Kuruvilla, J, Lambie, A, Lipton, J H, Loach, D, Messner, H A

“…Allo-SCT is potentially curative for patients with AML. Patients transplanted in CR2 tend to experience inferior survival compared with those in CR1. We…”
Get full text

Patient age, remission status and HCT-CI in a combined score are prognostic for patients with AML undergoing allogeneic hematopoietic cell transplantation in CR1 and CR2 by Michelis, F V, Messner, H A, Atenafu, E G, McGillis, L, Lambie, A, Uhm, J, Alam, N, Seftel, M D, Gupta, V, Kuruvilla, J, Lipton, J H, Kim, D D

“…For AML, older age, advanced disease and increased hematopoietic cell transplant comorbidity index (HCT-CI) are associated with worse prognosis following…”
Get full text

Risk stratification of organ-specific GVHD can be improved by single-nucleotide polymorphism-based risk models by Kim, D, Won, H-H, Su, S, Cheng, L, Xu, W, Hamad, N, Uhm, J, Gupta, V, Kuruvilla, J, Messner, H A, Lipton, J H

“…We aimed to develop a risk model, based on single-nucleotide polymorphism (SNP) markers associated with an increased risk of organ-specific GVHD in 394…”
Get full text

High-Dose Ibuprofen for Patent Ductus Arteriosus in Extremely Preterm Infants: A Randomized Controlled Study by Dani, C, Vangi, V, Bertini, G, Pratesi, S, Lori, I, Favelli, F, Ciuti, R, Bandinelli, A, Martano, C, Murru, P, Messner, H, Schena, F, Mosca, F

“…Our aim was to assess the hypothesis that a high‐dose regimen of ibuprofen is more effective than the standard‐dose regimen in closing patent ductus arteriosus…”
Get full text

Relationship between neurocognitive functioning and medication management ability over the first 6 months following allogeneic stem cell transplantation by Mayo, S, Messner, H A, Rourke, S B, Howell, D, Victor, J C, Kuruvilla, J, Lipton, J H, Gupta, V, Kim, D D, Piescic, C, Breen, D, Lambie, A, Loach, D, Michelis, F V, Alam, N, Uhm, J, McGillis, L, Metcalfe, K

“…Although neurocognitive impairment has been established as a major issue among cancer survivors, the real-world consequences of this impairment are unclear…”
Get full text

Comparable outcomes post allogeneic hematopoietic cell transplant for patients with de novo or secondary acute myeloid leukemia in first remission by Michelis, F V, Atenafu, E G, Gupta, V, Kim, D D, Kuruvilla, J, Lipton, J H, Loach, D, Seftel, M D, Uhm, J, Alam, N, Lambie, A, McGillis, L, Messner, H A

“…Secondary AML (sAML) has a poor prognosis with conventional chemotherapy alone. Allogeneic hematopoietic cell transplantation (HCT) is beneficial for high-risk…”
Get full text

Outcomes of patients with therapy-related AML/myelodysplastic syndrome (t-AML/MDS) following hematopoietic cell transplantation by Alam, N, Atenafu, E G, Kuruvilla, J, Uhm, J, Lipton, J H, Messner, H A, Kim, D H, Seftel, M, Gupta, V

“…We studied outcomes of 65 consecutive patients with therapy-related AML/myelodyplastic syndrome (t-AML/MDS) who underwent allogeneic hematopoietic cell…”
Get full text

A unique case of tuberculosis dissemination presenting as cutaneous lesions in a post allogeneic stem cell transplant patient by Lam, W, Viswabandya, A, Hussain, S, Messner, H A, Michelis, F V, Kim, D D, Lipton, J H, Deotare, U

Get full text

International Pediatric Otolaryngology Group (IPOG) consensus recommendations: Evaluation and management of congenital tracheal stenosis by Sidell, Douglas R., Meister, Kara D., de Alarcon, Alessandro, Boudewyns, An, Brigger, Matthew, Chun, Robert, Fayoux, Pierre, Goudy, Steven, Hart, Catherine K., Hewitt, Richard, Hsu, Wei-Chung, Javia, Luv R., Johnson, Romaine F., Messner, Anna H., Moreddu, Eric, Nicollas, Richard, Prager, Jeremy D., Rahbar, Reza, Rickert, Scott, Rossi, Marie-Eva, Russell, John, Rutter, Michael, Sandu, Kishore, Smith, Richard J.H., Soma, Marlene, Thierry, Briac, Trozzi, Marilena, White, David R., Balakrishnan, Karthik

“…To outline an expert-based consensus of recommendations for the diagnosis and management of pediatric patients with congenital tracheal stenosis. Expert…”
Get full text

Pediatric vocal fold paralysis after cardiac surgery: Rate of recovery and sequelae by Truong, Mai Thy, Messner, Anna H., Kerschner, Joseph E., Scholes, Melissa, Wong-Dominguez, Jaime, Milczuk, Henry A., Yoon, Patricia J.

“…To determine the rate of recovery of pediatric vocal fold paralysis (VFP) after cardiac surgery. Retrospective case series from January 2000 to 2005 at 4…”
Get full text

Premature newborns with fatal intrauterine herpes simplex virus-1 infection: first report of twins and review of the literature by Pichler, M., Staffler, A., Bonometti, N., Messner, H., Deluca, J., Thuile, T., Kluge, R., Schmuth, M., Eisendle, K.

“…Background Neonates with blistering skin diseases are dermatologic emergencies. The pathologies involved can pose diagnostic difficulties and there exists a…”
Get full text

A short tale of blood, kidney and brain: BK virus encephalitis in an allogeneic stem cell transplant recipient by Bourlon, C, Alamoudi, S, Kumar, D, Viswabandya, A, Thyagu, S, Michelis, F V, Kim, D (D-H), Lipton, J H, Messner, H A, Deotare, U

Get full text

Risk model incorporating donor IL6 and IFNG genotype and gastrointestinal GVHD can discriminate patients at high risk of steroid refractory acute GVHD by Alam, N, Xu, W, Atenafu, E G, Uhm, J, Seftel, M, Gupta, V, Kuruvilla, J, Lipton, J H, Messner, H A, Kim, D D H

“…Steroid refractory acute GVHD (SR aGVHD) is associated with high morbidity and mortality. This study attempted to generate a risk model for SR aGVHD using 259…”
Get full text

A retrospective comparison of conventional intensity conditioning and reduced-intensity conditioning for allogeneic hematopoietic cell transplantation in myelofibrosis by Gupta, V, Kröger, N, Aschan, J, Xu, W, Leber, B, Dalley, C, Sabloff, M, Lipton, J H, Messner, H, Brune, M

Get full text

Long-Term Medical Outcomes and Quality-of-Life Assessment of Patients With Chronic Myeloid Leukemia Followed at Least 10 Years After Allogeneic Bone Marrow Transplantation by KISS, T. L, ABDOLELL, M, JAMAL, N, MINDEN, LIPTON, J. H, MESSNER, H. A

“…Benchmark analysis of patients with chronic myeloid leukemia (CML) alive for more than 10 years after allogeneic bone marrow transplantation (BMT) including…”
Get full text

Long-term follow-up of secondary malignancies in adults after allogeneic bone marrow transplantation by HASEGAWA, W, POND, G. R, RIFKIND, J. T, MESSNER, H. A, LAU, A, DALY, A. S, KISS, T. L, KOTCHETKOVA, N, GALAL, A, LIPTON, J. H

“…The purpose of this study was to evaluate the estimated incidence of secondary malignancies post-allogeneic bone marrow transplantation (BMT) in a cohort of…”
Get full text